ORKA · Oruka Therapeutics, Inc. · Proposed Sales
Market Cap
$6.06B
Shares
66.21M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-01 | LAURA SANDLER | Officer | 5,000 | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | LAWRENCE KLEIN | Director, Officer | 75,000 | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-14 | PAUL QUINLAN | Officer | 71,000 | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-15 | JOANA GONCALVES | Officer | 21,000 | 2026-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-13 | Arjun Agarwal | Officer | 28,588 | 2026-07-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-01 | Fairmount Healthcare Fund II L.P. | Director, 10% Stockholder | 3,553,410 | 2026-07-01 | Goldman Sachs & Co. LLC |
| 2026-06-11 | CARL DAMBKOWSKI | Director | 35,000 | 2026-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-21 | CARL DAMBKOWSKI | Director | 105,000 | 2026-05-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-18 | ARJUN AGARWAL | Officer | 22,206 | 2026-05-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | LAURA SANDLER | Officer | 10,000 | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | JOANA GONCALVES | Officer | 21,000 | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-02 | LAURA SANDLER | Officer | 18,000 | 2026-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-19 | JOANA GONCALVES | Officer | 28,000 | 2025-12-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–13 of 13 filings
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
172 filings
172 filers
Visit website
Investor relations